Skip to main content

Abstract: Cosmetic Gynecology & Endopeel

Prospective study in cosmetic gynecology through the application of Endopeel combined with PRP. Preliminary results.
Dr. Alain Tenenbaum (1), Mr. Mauro Tiziani (2),Dr. Ariel Luksenburg ,Dr. Juan Barcia ,Dr. Roberto Sergio 

 

The treatment with Endopeel techniques is recognized as one of the best alternatives for the recovery of the firmness of the tissues for cosmetic purposes.

The localized deep and subdermal injections recover the lines of tension of the skin and produce an increase in the tone of the subcutaneous muscle by mechanisms linked to an endogenous response of tissue to the injected components.
The following study presents a series of patients who underwent injections of  Endopeel products ,technique for the cosmetic treatment of the female genital area.
Twenty women 46 to 67 years of age, with asymmetric vulvar sagging and deformation, along with distension of the vaginal introitus and flaccidity of the vaginal walls, were injected with the Endopeel techniques and products at the level of the labia majora, vulvar hairpin and vaginal walls, And with PRP, the labia minora.
Control was performed 30 and 60 days after injection. Clinically the cutaneous tissues showed retraction and recovery of the form with symmetry, with a marked increase in the firmness of the superficial and deep planes, depending on the case.
In 10 cases of patients who associated vaginal dryness, intravaginal PRP was injected with recovery of the natural lubrication of the vaginal mucosa.
The Endopeel, demonstrates a high capacity of vulvo-vaginal morphological rejuvenation and offers a promising perspective for gyneco-cosmetic treatments. The combination with endovaginal PRP increases patient satisfaction by improving natural lubrication. Endopeel also hydrates treated tissues. (Dr.Ercin Ozüntürk- Sir.Mauro Tiziani)

 

(1) Specialist in facial plastic surgery- Switzerland- Inventor of Endopeel - e mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

(2) Molecular Biologist-Switzerland- Co Inventor of Endopeel- e mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract : Urinary Incontinence & Endopeel

Successful treatment of urinary incontinence to the effort by the combined use of injections of Endopeel Products + PRP and placement of PDO threads.

Dr. Alain Tenenbaum (1), Mr. Mauro Tiziani (2),Dr. Ariel Luksenburg , Dr. Juan J. Barcia ,Dr. Roberto Sergio

Urine incontinence to stress is a major clinical problem affecting millions of women around the world. Loss of urine is related to increased intra-abdominal pressure and may have an anatomic cause (due to urethral hypermobility in which the urethral support elements are weakened or damaged) or intrinsic functional defect of the sphincter, Of both factors.
Taking into account the anatomo-functional bases of the pathology, we have developed a minimally invasive treatment to achieve toning the pelvic floor muscles, increasing the resistance of the urethra so that the intravesical pressure does not exceed the urethral during the exertions.

23 women between the ages of 38 and 62 with mild to moderate urinary stress incontinence with complete urodynamic studies were carefully selected and treated by placement of resorbable PDO (Polidioxanone) threads, vaginally, for urethral Longitudinal, along with injections of Endopeel + PRP in the periurethral muscles of the pelvic floor.

PDO strings are placed with the aid of a device specially designed for intra-vaginal approach, guided by a "fenestrated" speculum, developed to fit the course of the urethra (urethral protection) and the injections are applied with cannula type "Ballonet", of appropriate length, designed to reach precise anatomical levels.

Between 30 and 60 days post-treatment days, a complete cessation of urine loss to effort and normal urodynamic studies is observed.

The combined use of PDO threads + Endopeel + PRP  initially generates a pelvic floor tension and then localized and controlled fibrosis that elevates the sphincter unit and produces functional recovery without side effects.

The treatment described is a new economic alternative, fast acting, with no side effects and effective in 87% and partially effective in 13%* of the cases studied until the moment of stress urinary incontinence.
* With significant partial improvements with 2 treatments performed. Upcoming treatments

(1) Specialist in facial plastic surgery- Switzerland- Inventor of Endopeel- e mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
(2) Molecular Biologist-Switzerland- Co Inventor of Endopeel- e mail: This email address is being protected from spambots. You need JavaScript enabled to view it.